Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast

Area of Science:

• Rheumatology
• Immunology
• Pathogenesis of Autoimmune Diseases

Background:

• Systemic sclerosis (SSc) is a complex autoimmune disease characterized by inflammation, fibrosis, and vasculopathy.
• These pathogenic pathways contribute to significant skin and internal organ damage in patients.
• Recent research highlights the intricate roles of both innate and acquired immune systems in SSc.

Purpose of the Study:

• To provide a comprehensive review of the current understanding of Systemic Sclerosis pathogenesis.
• To discuss the key pathogenic mechanisms driving SSc, including inflammation, fibrosis, and vasculopathy.
• To identify and analyze emerging therapeutic targets linked to these mechanisms.

Main Methods:

• Review of recent scientific literature on Systemic Sclerosis.
• Analysis of preclinical and clinical trial data for therapeutic targets.
• Synthesis of information on immune system involvement in SSc pathogenesis.

Main Results:

• The interplay between innate and acquired immunity is crucial in SSc pathogenesis.
• Several therapeutic targets have been identified based on pathogenic mechanisms.
• These targets have shown variable results in preclinical and clinical investigations.

Conclusions:

• A deeper understanding of SSc pathogenesis, particularly immune system interactions, is advancing treatment strategies.
• Identifying specific pathogenic pathways allows for the development of targeted therapies.
• Continued research and clinical trials are essential to optimize therapeutic outcomes for Systemic Sclerosis.